Atorvastatin EP Impurity D (D2)

Atorvastatin EP Impurity D (D2)

VS CAT No VS-A037055
CAS No 873950-19-7
Mol.F. C26H24FNO5
Mol.Wt. 449.5
Inv. Status Custom Synthesis

Chemical Name: (1Ξ,2Ξ,4Ξ,5Ξ)-4-(4-fluorophenyl)-2,4-dihydroxy-N,5-diphenyl-2-(propan-2-yl)-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide (D2), (as per EP) ; 4-(4-Fluorophenyl)-2,4-dihydroxy-2-(1-methylethyl)-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide (as per USP)

Synonym: Atorvastatin Epoxy Tetrahydrofuran Analog (USP)

Shipping Temperature: Ambient

Country of Origin: India

Smiles: O=C(NC1=CC=CC=C1)C2(O3)C(O)(C(C)C)OC(C4=CC=C(F)C=C4)(O)C23C5=CC=CC=C5

Atorvastatin EP Impurity D (D2) is chemically (1Ξ,2Ξ,4Ξ,5Ξ)-4-(4-fluorophenyl)-2,4-dihydroxy-N,5-diphenyl-2-(propan-2-yl)-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide (D2), (as per EP) ; 4-(4-Fluorophenyl)-2,4-dihydroxy-2-(1-methylethyl)-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide (as per USP). It is also known as Atorvastatin Epoxy Tetrahydrofuran Analog (USP). Atorvastatin EP Impurity D (D2) is supplied with detailed characterization data compliant with regulatory guideline. Atorvastatin EP Impurity D (D2) can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Atorvastatin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. Vsquare products are for analytical purpose only and not for human use.